Biogen Inc

LTS : 0R1B

USA·Healthcare·Drug Manufacturers

$234.71

+3.21 (+1.73%)Oct 16 close

Market Cap

$34.45B

Enterprise Value

$37.21B

P/E (TTM)

26.77

P/B

1.90

Net Cash / (Debt)

−$2.76B

52-Week Range

$146 — $238

5-Year Range

$114 — $316

Avg Volume (3M)

947

Biogen Inc to Discuss Aducanumab Phase 3 Topline Results at AAN Presentation Transcript

2020-05-18Corporate Presentation

Read the full earnings transcript with Waltermetrics Pro

The complete transcript text is available to Pro members.